UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030892
Receipt No. R000034363
Scientific Title Phase 2 trial of first-line combination therapy of cisplatin, pemetrexed and nivolumab in participants with unresectable malignant pleural mesothelioma
Date of disclosure of the study information 2018/01/19
Last modified on 2019/10/29 13:18:08

No. Disposal Last modified on Item of update
1 Insert 2018/01/19 14:23:53
2 Update 2018/02/16 13:05:41 Recruitment status
3 Update 2018/07/23 09:44:23 Key exclusion criteria
Key exclusion criteria
4 Update 2018/07/23 09:46:28 Key secondary outcomes
Key secondary outcomes
5 Update 2019/06/03 10:39:20 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Address
Address
Address
Address
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/06/03 10:49:33 Recruitment status
Date of IRB
Last follow-up date
7 Update 2019/06/03 11:32:20 Number of participants that the trial has enrolled
8 Update 2019/06/25 10:44:50 Key exclusion criteria
9 Update 2019/10/29 13:15:29 Last follow-up date
10 Update 2019/10/29 13:18:08 Last follow-up date


Contact us.